Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy (Q44308111)

1 December 2017

Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy (English)

1 reference

1 December 2017

James C Cloyd

1

1 reference

1 December 2017

Sandeep Dutta

2

1 reference

1 December 2017

Guoliang Cao

3

1 reference

1 December 2017

Julia K Walch

4

1 reference

1 December 2017

Stephen D Collins

5

1 reference

1 December 2017

G Richard Granneman

6

1 reference

1 December 2017

Depacon Study Group

7

1 reference

1 December 2017

1 February 2003

1 reference

1 December 2017

1 reference

1 December 2017

53

1 reference

1 December 2017

1-2

1 reference

1 December 2017

19-27

1 reference

Bidirectional interaction of valproate and lamotrigine in healthy subjects.

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Variable free and total valproic acid concentrations in sole- and multi-drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Intravenous phenytoin: Clinical and pharmacokinetic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Effect of infusion duration on valproate pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Pharmacokinetics and bioavailability of sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

The safety of rapid valproic acid infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Time course of carbamazepine autoinduction. The VA Cooperative Study No.118 Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Intravenous loading of valproate for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

The pharmacokinetics of valproic acid after oral and parenteral administration in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Effect of Altered Plasma Protein Binding on Apparent Volume of Distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Disposition of sodium valproate in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Safety and tolerance of rapidly infused Depacon. A randomized trial in subjects with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Rapid reversibility of autoinduction of carbamazepine metabolism after temporary discontinuation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Intravenous valproate is well tolerated in unstable patients with status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Treatment of status epilepticus in children with rectal sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Rectal valproate syrup and status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900251-6

7 January 2021

10.1016/S0920-1211(02)00251-6

Identifiers

DOI

1 reference

1 December 2017

1 reference